First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study-Reference-Cited by-同舟云学术

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

Published:2020 Issue:1 Volume:5 Page:e000587
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Taieb Julien^ORCID,Prager Gerald W.^ORCID,Melisi Davide,Westphalen C. Benedikt,D'Esquermes Nathalie,Ferreras Anabel,Carrato Alfredo,Macarulla Teresa

Funder

Shire

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030;Quante;Cancer Med,2016

3. European cancer mortality predictions for the year 2018 with focus on colorectal cancer;Malvezzi;Ann Oncol,2018

4. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018

5. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phenotypic Approach to the Discovery of Potent G-Quadruplex Targeted Drugs;Molecules;2024-08-01

2. Evaluation of the Treatment Duration of Japanese Patients With Pancreatic Cancer in a Real-World Setting Using a Large Hospital Claims Database;Pancreas;2024-05-16

3. Talaromides A–C, Bioactive Cyclic Heptapeptides from Talaromyces siglerae Isolated from a Marine Sponge;Journal of Natural Products;2024-04-16

4. Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group;ESMO Open;2024-04

5. Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study;Journal of Clinical Oncology;2024-03-20